Calypso Medical Technologies Inc. raised $6.4 million from what it hopes will be a $7.5 million funding round.
Twenty-seven unnamed investors have participated in the debt and options-based round thus far. The first sale of securites occured on Jan. 6, according to a Securities & Exchange Commission filing.
The Seattle-based company makes a system for targeted prostate cancer radiation therapy. In October, it won 510(k) clearance from the Food and Drug Administration for the Calypso System with "Dynamic Edge Gating Technology," which "automates the response to organ motion that occurs during the delivery of radiation… in order to protect healthy tissue from unintended radiation," according to the company.
Here’s a roundup of the latest dealflow and investment news:
- EyeSense Attracts QIAGEN as Strategic Investor
EyeSense AG, a developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, announced that it entered into a strategic partnership with QIAGEN (NSDQ:QGEN). Capitalizing on QIAGEN’s ESE fluorescence-based optical technology and on Eyesense’s glucose sensing technology, the partners intend to develop a new optical measurement technology for blood glucose monitoring in diabetes patients. QIAGEN acquired a minority equity stake in EyeSense and attained royalty rights for future commercialization.
- Century Park Capital Partners Announces the Recapitalization of Cirtec Medical Systems LLC
Century Park Capital Partners announced that it led the recapitalization of Cirtec Medical Systems LLC along with Charter Oak Equity and the company’s founders. Cirtec is a provider of client focused, comprehensive medical product design, engineering and manufacturing solutions. Cirtec was formed in 2009 from the merger of Circle Medical Devices and Texcel Medical. The company operates out of locations in Los Gatos, Calif. and East Longmeadow, Mass.
- iMedX drums up $2.5 million
iMedX Inc. raised $2.5 million in equity financing from nine different investors, according to a filing with the Securities & Exchange Commission. The Shelton, Conn.-based company provides medical transcription software and services and is backed by New Canaan, Conn.-based RFE Investment Partners. Last September, the company raised $1.5 million, according to a regulatory filing.
- OrthoCor lands $1.5 million from angels
OrthoCor Medical Inc., a Minneapolis-based startup that makes an FDA-approved knee brace, has raised $1.5 million from angel investors, reported MedCity News. OrthoCor was one of the first of more than 100 small businesses to register for Minnesota’s angel investment tax credit. About half of the money it raised came from investors who used the credit. OrthoCor, which started out at the University Enterprise Laboratories incubator in St. Paul, received approval from the FDA for its OrthoCor Active Knee System in Dec. 2009.